Drug Shortage Report for M-RANITIDINE

Last updated on 2021-07-30 History
Report ID 127450
Drug Identification Number 02473534
Brand name M-RANITIDINE
Common or Proper name M-Ranitidine
Company Name MANTRA PHARMA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-10-28
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-07-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1000 RUE DU LUX SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-10-28 English Compare
v2 2020-10-28 French Compare
v3 2020-10-29 English Compare
v4 2020-12-24 English Compare
v5 2020-12-24 French Compare
v6 2021-01-15 English Compare
v7 2021-01-15 French Compare
v8 2021-02-05 English Compare
v9 2021-02-05 French Compare
v10 2021-03-05 English Compare
v11 2021-03-05 French Compare
v12 2021-03-26 English Compare
v13 2021-03-26 French Compare
v14 2021-04-09 English Compare
v15 2021-04-09 French Compare
v16 2021-04-16 English Compare
v17 2021-04-16 French Compare
v18 2021-04-23 English Compare
v19 2021-04-23 French Compare
v20 2021-04-30 English Compare

Showing 1 to 20 of 47